{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:26:06Z","timestamp":1792189566100,"version":"4.4.0"},"reference-count":165,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.addr.2010.08.004","type":"journal-article","created":{"date-parts":[[2010,8,14]],"date-time":"2010-08-14T05:02:05Z","timestamp":1281762125000},"page":"1052-1063","source":"Crossref","is-referenced-by-count":1152,"title":["Imaging and drug delivery using theranostic nanoparticles"],"prefix":"10.1016","volume":"62","author":[{"given":"Siti M.","family":"Janib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ara S.","family":"Moses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Andrew","family":"MacKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2010.08.004_bb0005","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/nbt872","article-title":"The \u2018right\u2019 size in nanobiotechnology","volume":"21","author":"Whitesides","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2010.08.004_bb0010","first-page":"99","article-title":"Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer","volume":"4","author":"Miele","year":"2009","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.addr.2010.08.004_bb0015","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.tips.2009.08.004","article-title":"Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer","volume":"30","author":"Malam","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.addr.2010.08.004_bb0020","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1097\/CCM.0b013e3181921349","article-title":"Toward theragnostics","volume":"37","author":"Pene","year":"2009","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.addr.2010.08.004_bb0025","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/sj.bjp.0707130","article-title":"Nanoparticles: pharmacological and toxicological significance","volume":"150","author":"Medina","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.addr.2010.08.004_bb0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/wnan.66","article-title":"Nanomaterial standards for efficacy and toxicity assessment","volume":"2","author":"Adiseshaiah","year":"2010","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.addr.2010.08.004_bb0035","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/wnan.63","article-title":"Maximizing safe design of engineered nanomaterials: the NIH and NIEHS research perspective","volume":"2","author":"Tinkle","year":"2010","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.addr.2010.08.004_bb0040","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1161\/ATVBAHA.109.193086","article-title":"Hybrid in vivo FMT-CT imaging of protease activity in atherosclerosis with customized nanosensors","volume":"29","author":"Nahrendorf","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.addr.2010.08.004_bb0045","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00418-008-0511-y","article-title":"Molecular imaging with nanoparticles: giant roles for dwarf actors","volume":"130","author":"Debbage","year":"2008","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.addr.2010.08.004_bb0050","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1101\/gad.1047403","article-title":"Molecular imaging in living subjects: seeing fundamental biological processes in a new light","volume":"17","author":"Massoud","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.addr.2010.08.004_bb0055","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/adfm.200801655","article-title":"New generation of multifunctional nanoparticles for cancer imaging and therapy","volume":"19","author":"Park","year":"2009","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.addr.2010.08.004_bb0060","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/030089160809400219","article-title":"Nanoparticles for imaging and tumor gene delivery","volume":"94","author":"Richard","year":"2008","journal-title":"Tumori"},{"key":"10.1016\/j.addr.2010.08.004_bb0065","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10555-008-9158-3","article-title":"Imaging of integrin alphavbeta3 expression","volume":"27","author":"Beer","year":"2008","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.addr.2010.08.004_bb0070","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.nucmedbio.2007.03.007","article-title":"Targeted alpha-particle radiotherapy with 211at-labeled monoclonal antibodies","volume":"34","author":"Zalutsky","year":"2007","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.addr.2010.08.004_bb0075","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2214\/AJR.05.0523","article-title":"A liposomal nanoscale contrast agent for preclinical CT in mice","volume":"186","author":"Mukundan","year":"2006","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.addr.2010.08.004_bb0080","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1136\/bmj.322.7296.1222","article-title":"Microbubble contrast agents: a new era in ultrasound","volume":"322","author":"Blomley","year":"2001","journal-title":"BMJ."},{"key":"10.1016\/j.addr.2010.08.004_bb0085","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1007\/s10439-009-9640-2","article-title":"Design of multifunctional nanomedical systems","volume":"37","author":"Haglund","year":"2009","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.addr.2010.08.004_bb0090","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.addr.2007.08.044","article-title":"Protein nanoparticles as drug carriers in clinical medicine","volume":"60","author":"Hawkins","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2010.08.004_bb0095","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/978-1-60761-609-2_26","article-title":"Liposomal doxorubicin and nab-paclitaxel: nanoparticle cancer chemotherapy in current clinical use","volume":"624","author":"Gaitanis","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.addr.2010.08.004_bb0100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0168-3659(03)00216-5","article-title":"Evaluation of an elastin-like polypeptide-doxorubicin conjugate for cancer therapy","volume":"91","author":"Dreher","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2010.08.004_bb0105","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jconrel.2005.10.006","article-title":"Structural optimization of a \u201cSmart\u201d Doxorubicin-polypeptide conjugate for thermally targeted delivery to solid tumors","volume":"110","author":"Furgeson","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2010.08.004_bb0110","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10637-007-9053-8","article-title":"A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance","volume":"25","author":"Bidwell","year":"2007","journal-title":"Invest New Drugs."},{"key":"10.1016\/j.addr.2010.08.004_bb0115","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.bcp.2006.10.028","article-title":"Development of elastin-like polypeptide for thermally targeted delivery of doxorubicin","volume":"73","author":"Bidwell","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.addr.2010.08.004_bb0120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.addr.2009.12.004","article-title":"HPMA copolymers: 30years of advances","volume":"62","author":"Lammers","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2010.08.004_bb0125","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.addr.2009.10.004","article-title":"HPMA copolymers: origins, early developments, present, and future","volume":"62","author":"Kopecek","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2010.08.004_bb0130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.addr.2009.11.028","article-title":"Improving the efficacy of combined modality anticancer therapy using HPMA copolymer-based nanomedicine formulations","volume":"62","author":"Lammers","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2010.08.004_bb0135","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.addr.2009.11.027","article-title":"HPMA copolymer-cyclic RGD conjugates for tumor targeting","volume":"62","author":"Pike","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2010.08.004_bb0140","doi-asserted-by":"crossref","DOI":"10.3109\/10611860903115282","article-title":"HPMA-copolymer conjugates targeted to tumor endothelium using synthetic oligopeptides","author":"Pola","year":"2009","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2010.08.004_bb0145","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.addr.2009.12.007","article-title":"Molecular imaging of HPMA copolymers: visualizing drug delivery in cell, mouse and man","volume":"62","author":"Lu","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2010.08.004_bb0150","first-page":"83","article-title":"Phase I clinical and pharmacokinetic study of PK1 [n-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents\u2013drug-polymer conjugates. Cancer research campaign phase I\/II committee","volume":"5","author":"Vasey","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2010.08.004_bb0155","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1016\/j.biomaterials.2009.02.040","article-title":"Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers","volume":"30","author":"Lammers","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2010.08.004_bb0160","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2008.07.014","article-title":"Tumor-targeted HPMA copolymer-(RGDfK)-(CHX-A\u2033-DTPA) conjugates show increased kidney accumulation","volume":"132","author":"Borgman","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2010.08.004_bb0165","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1007\/s11095-007-9252-1","article-title":"Noninvasive visualization of pharmacokinetics, biodistribution and tumor targeting of poly[n-(2-hydroxypropyl)methacrylamide] in mice using contrast enhanced mri","volume":"24","author":"Wang","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2010.08.004_bb0170","first-page":"689","article-title":"Novel applications of nanotechnology in medicine","volume":"130","author":"Surendiran","year":"2009","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.addr.2010.08.004_bb0175","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/nbt1171","article-title":"Designing dendrimers for biological applications","volume":"23","author":"Lee","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2010.08.004_bb0180","first-page":"561","article-title":"Vivagel (spl7013 gel): a candidate dendrimer\u2014microbicide for the prevention of hiv and hsv infection","volume":"2","author":"Rupp","year":"2007","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.addr.2010.08.004_bb0185","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.bmcl.2009.11.065","article-title":"Dendrimer-based tumor cell targeting of fibroblast growth factor-1","volume":"20","author":"Thomas","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.addr.2010.08.004_bb0190","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1039\/b927215c","article-title":"Light-controlled release of caged doxorubicin from folate receptor-targeting pamam dendrimer nanoconjugate","volume":"46","author":"Choi","year":"2010","journal-title":"Chem. Commun. (Camb)."},{"key":"10.1016\/j.addr.2010.08.004_bb0195","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1021\/bc010103m","article-title":"Polyester dendritic systems for drug delivery applications: in vitro and in vivo evaluation","volume":"13","author":"Padilla De Jesus","year":"2002","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2010.08.004_bb0200","doi-asserted-by":"crossref","first-page":"16649","DOI":"10.1073\/pnas.0607705103","article-title":"A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing c-26 colon carcinomas","volume":"103","author":"Lee","year":"2006","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.addr.2010.08.004_bb0205","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1021\/bc700264g","article-title":"Pegylated dendrimers with core functionality for biological applications","volume":"19","author":"Guillaudeu","year":"2008","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2010.08.004_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mrm.1910310102","article-title":"Dendrimer-based metal-chelates \u2014 a new class of magnetic-resonance-imaging contrast agents","volume":"31","author":"Wiener","year":"1994","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.addr.2010.08.004_bb0215","doi-asserted-by":"crossref","unstructured":"S.A. Kularatne and P.S. Low, Targeting of nanoparticles: Folate receptor, Methods Mol Biol. 624 (2010) 249\u2013265.","DOI":"10.1007\/978-1-60761-609-2_17"},{"key":"10.1016\/j.addr.2010.08.004_bb0220","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1352-8661(01)00106-5","article-title":"Specific targeting of folate-dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts","volume":"12","author":"Konda","year":"2001","journal-title":"Magn. Reson. Mater. Phys., Biol. Med."},{"key":"10.1016\/j.addr.2010.08.004_bb0225","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1021\/bc800125u","article-title":"Folate and folate-PEG-PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice","volume":"19","author":"Singh","year":"2008","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2010.08.004_bb0230","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3181\/0702-RM-33","article-title":"In vivo evaluation of a PAMAM-cystamine-(Gd-DO3A) conjugate as a biodegradable macromolecular mri contrast agent","volume":"232","author":"Xu","year":"2007","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.addr.2010.08.004_bb0235","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1073\/pnas.0811757106","article-title":"Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis","volume":"106","author":"Almutairi","year":"2009","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.addr.2010.08.004_bb0240","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1007\/s002590000293","article-title":"Monoclonal antibody\u2013dendrimer conjugates enable radiolabeling of antibody with markedly high specific activity with minimal loss of immunoreactivity","volume":"27","author":"Kobayashi","year":"2000","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.addr.2010.08.004_bb0245","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1021\/bc980091d","article-title":"Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody","volume":"10","author":"Kobayashi","year":"1999","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2010.08.004_bb0250","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1021\/nl020246x","article-title":"Novel iodinated dendritic nanoparticles for computed tomography (CT) imaging","volume":"2","author":"Yordanov","year":"2002","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2010.08.004_bb0255","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2147\/IJN.S4937","article-title":"Nanomedicine in pulmonary delivery","volume":"4","author":"Mansour","year":"2009","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.addr.2010.08.004_bb0260","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrd1632","article-title":"Recent advances with liposomes as pharmaceutical carriers","volume":"4","author":"Torchilin","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2010.08.004_bb0265","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ymeth.2008.05.006","article-title":"Polymersomes: a new multi-functional tool for cancer diagnosis and therapy","volume":"46","author":"Levine","year":"2008","journal-title":"Methods"},{"key":"10.1016\/j.addr.2010.08.004_bb0270","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijpharm.2010.02.014","article-title":"Biophysical characterization of a liposomal formulation of cytarabine and daunorubicin","volume":"391","author":"Dicko","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2010.08.004_bb0275","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.leukres.2008.06.028","article-title":"In vivo maintenance of synergistic cytarabine:Daunorubicin ratios greatly enhances therapeutic efficacy","volume":"33","author":"Tardi","year":"2009","journal-title":"Leuk. Res."},{"key":"10.1016\/j.addr.2010.08.004_bb0280","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.leukres.2010.01.015","article-title":"Leukemia-selective uptake and cytotoxicity of cpx-351, a synergistic fixed-ratio cytarabine: Daunorubicin formulation, in bone marrow xenografts","volume":"34","author":"Lim","year":"2010","journal-title":"Leuk. Res."},{"key":"10.1016\/j.addr.2010.08.004_bb0285","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1002\/jps.21620","article-title":"Pharmacokinetics of CPX-351 (cytarabine\/daunorubicin HCl) liposome injection in the mouse","volume":"98","author":"Bayne","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2010.08.004_bb0290","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/978-1-60327-360-2_22","article-title":"Gadolinium-loaded polychelating polymer-containing tumor-targeted liposomes","volume":"605","author":"Erdogan","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.addr.2010.08.004_bb0295","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1021\/mp800187d","article-title":"Tumor targeting of functionalized quantum dot-liposome hybrids by intravenous administration","volume":"6","author":"Al-Jamal","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2010.08.004_bb0300","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10456-010-9165-1","article-title":"Paramagnetic and fluorescent liposomes for target-specific imaging and therapy of tumor angiogenesis","volume":"13","author":"Strijkers","year":"2010","journal-title":"Angiogenesis"},{"key":"10.1016\/j.addr.2010.08.004_bb0305","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/02656730600582956","article-title":"Hyperthermia mediated liposomal drug delivery","volume":"22","author":"Ponce","year":"2006","journal-title":"Int. J. Hyperthermia"},{"key":"10.1016\/j.addr.2010.08.004_bb0310","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1158\/1535-7163.1311.3.10","article-title":"Targeting tumor microvessels using doxorubicin encapsulated in a novel thermosensitive liposome","volume":"3","author":"Chen","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.addr.2010.08.004_bb0315","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1148\/radiology.171.1.2928550","article-title":"Hepatic metastases: liposomal Gd-DTPA-enhanced MR imaging","volume":"171","author":"Unger","year":"1989","journal-title":"Radiology"},{"key":"10.1016\/j.addr.2010.08.004_bb0320","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0730-725X(94)00083-F","article-title":"Controlled delivery of Gd-containing liposomes to lymph nodes: surface modification may enhance MRI contrast properties","volume":"13","author":"Trubetskoy","year":"1995","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.addr.2010.08.004_bb0325","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1021\/js950407f","article-title":"Development of inherently echogenic liposomes as an ultrasonic contrast agent","volume":"85","author":"Alkan-Onyuksel","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2010.08.004_bb0330","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1021\/js9603515","article-title":"In vitro targeting of antibody-conjugated echogenic liposomes for site-specific ultrasonic image enhancement","volume":"86","author":"Demos","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2010.08.004_bb0335","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.284.5417.1143","article-title":"Polymersomes: tough vesicles made from diblock copolymers","volume":"284","author":"Discher","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.addr.2010.08.004_bb0340","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1126\/science.1074972","article-title":"Polymer vesicles","volume":"297","author":"Discher","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.addr.2010.08.004_bb0345","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1021\/bm1000026","article-title":"Self assembly of amphiphilic (PEG)(3)-PLA copolymer as polymersomes: preparation, characterization, and their evaluation as drug carrier","volume":"11","author":"Jain","year":"2010","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2010.08.004_bb0350","doi-asserted-by":"crossref","DOI":"10.1021\/la100641j","article-title":"Block copolymer systems: from single chain to self-assembled nanostructures","author":"Giacomelli","year":"2010","journal-title":"Langmuir"},{"key":"10.1016\/j.addr.2010.08.004_bb0355","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1021\/bm9006419","article-title":"Biomimetic doxorubicin loaded polymersomes from hyaluronan-block-poly(gamma-benzyl glutamate) copolymers","volume":"10","author":"Upadhyay","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2010.08.004_bb0360","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/mabi.200900415","article-title":"In vitro and in vivo evaluation of docetaxel loaded biodegradable polymersomes","volume":"10","author":"Upadhyay","year":"2010","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.addr.2010.08.004_bb0365","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jconrel.2004.09.026","article-title":"Biodegradable polymersomes as a basis for artificial cells: encapsulation, release and targeting","volume":"101","author":"Meng","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2010.08.004_bb0370","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejpb.2008.09.025","article-title":"Polymersome carriers: from self-assembly to siRNA and protein therapeutics","volume":"71","author":"Christian","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2010.08.004_bb0375","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/mabi.200900415","article-title":"In vitro and in vivo evaluation of docetaxel loaded biodegradable polymersomes","volume":"10","author":"Upadhyay","year":"2010","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.addr.2010.08.004_bb0380","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.biomaterials.2009.12.043","article-title":"The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(gamma-benzyl l-glutamate)-B-hyaluronan polymersomes","volume":"31","author":"Upadhyay","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2010.08.004_bb0385","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1016\/j.biomaterials.2010.03.055","article-title":"EGFP-EGF1 protein-conjugated PEG-PLA nanoparticles for tissue factor targeted drug delivery","volume":"31","author":"Mei","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2010.08.004_bb0390","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1109\/IEMBS.2006.259861","article-title":"Efficient nuclear delivery and nuclear body localization of antisense oligo-nucleotides using degradable polymersomes","volume":"1","author":"Kim","year":"2006","journal-title":"Conf. Proc. IEEE Eng. Med. Biol. Soc."},{"key":"10.1016\/j.addr.2010.08.004_bb0395","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jconrel.2008.10.020","article-title":"Polymersome delivery of siRNA and antisense oligonucleotides","volume":"134","author":"Kim","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2010.08.004_bb0400","doi-asserted-by":"crossref","unstructured":"M. Ao, Z. Wang, H. Ran, D. Guo, J. Yu, A. Li, W. Chen, W. Wu and Y. Zheng, Gd-DTPA-loaded PLGA microbubbles as both ultrasound contrast agent and MRI contrast agent\u2014a feasibility research, J Biomed Mater Res B Appl Biomater. 93 (2010) 551-556.","DOI":"10.1002\/jbm.b.31614"},{"key":"10.1016\/j.addr.2010.08.004_bb0405","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.jmmm.2003.12.416","article-title":"Nanoparticles of magnetic ferric oxides encapsulated with poly(d, l latide-co-glycolide) and their applications to magnetic resonance imaging contrast agent","volume":"272\u201376","author":"Lee","year":"2004","journal-title":"J. Magn. Magn. Mater."},{"key":"10.1016\/j.addr.2010.08.004_bb0410","doi-asserted-by":"crossref","unstructured":"C. Prashant, M. Dipak, C.T. Yang, K.H. Chuang, D. Jun, S.S. Feng, Superparamagnetic iron oxide--loaded poly(lactic acid)-D-alpha-tocopherol polyethylene glycol 1000 succinate copolymer nanoparticles as mri contrast agent, Biomaterials 31 (2010) 5588-5597.","DOI":"10.1016\/j.biomaterials.2010.03.070"},{"key":"10.1016\/j.addr.2010.08.004_bb0415","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.2174\/138161206779026263","article-title":"Formulation of drugs in block copolymer micelles: drug loading and release","volume":"12","author":"Liu","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.addr.2010.08.004_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-006-9132-0","article-title":"Micellar nanocarriers: pharmaceutical perspectives","volume":"24","author":"Torchilin","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2010.08.004_bb0425","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1007\/s00018-004-4153-5","article-title":"Targeted polymeric micelles for delivery of poorly soluble drugs","volume":"61","author":"Torchilin","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.addr.2010.08.004_bb0430","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.addr.2009.11.029","article-title":"Micelles based on HPMA copolymers","volume":"62","author":"Talelli","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2010.08.004_bb0435","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1021\/nl061412u","article-title":"Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems","volume":"6","author":"Nasongkla","year":"2006","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2010.08.004_bb0440","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0168-3659(01)00275-9","article-title":"In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy","volume":"72","author":"Kim","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2010.08.004_bb0445","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10549-007-9591-y","article-title":"Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer","volume":"108","author":"Lee","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.addr.2010.08.004_bb0450","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1093\/annonc\/mdm374","article-title":"Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer","volume":"18","author":"Kim","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.addr.2010.08.004_bb0455","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/annonc\/mdp315","article-title":"Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol-PM) in patients with solid tumors","volume":"21","author":"Lim","year":"2010","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.addr.2010.08.004_bb0460","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0730-725X(91)90425-L","article-title":"Gadolinium-labeled liposomes containing amphiphilic Gd-DTPA derivatives of varying chain-length \u2014 targeted MRI contrast enhancement agents for the liver","volume":"9","author":"Kabalka","year":"1991","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.addr.2010.08.004_bb0465","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/00004424-199008000-00009","article-title":"A pharmacokinetic and MRI study of unilamellar gadolinium-, manganese-, and iron-DTPA-stearate liposomes as organ-specific contrast agents","volume":"25","author":"Schwendener","year":"1990","journal-title":"Invest Radiol."},{"key":"10.1016\/j.addr.2010.08.004_bb0470","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0730-725X(91)90425-L","article-title":"Gadolinium-labeled liposomes containing amphiphilic Gd-DTPA derivatives of varying chain length: targeted MRI contrast enhancement agents for the liver","volume":"9","author":"Kabalka","year":"1991","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.addr.2010.08.004_bb0475","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0378-5173(89)90349-9","article-title":"Small unilamellar liposomes as magnetic resonance contrast agents loaded with paramagnetic Mn-, Gd-, and Fe-DTPA \u2013 stearate complexes","volume":"49","author":"Schwendener","year":"1989","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2010.08.004_bb0480","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0378-5173(91)90089-7","article-title":"Liposomes as carriers of 99mTc glucoheptonate for liver imaging","volume":"69","author":"Jaggi","year":"1991","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2010.08.004_bb0485","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1039\/b605615f","article-title":"New 64Cu PET imaging agents for personalised medicine and drug development using the hexa-aza cage, SarAr","volume":"4","author":"Di Bartolo","year":"2006","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.addr.2010.08.004_bb0490","doi-asserted-by":"crossref","first-page":"17489","DOI":"10.1073\/pnas.0708436104","article-title":"Positron emission tomography (PET) imaging of neuroblastoma and melanoma with 64Cu-SarAr immunoconjugates","volume":"104","author":"Voss","year":"2007","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.addr.2010.08.004_bb0495","doi-asserted-by":"crossref","unstructured":"H. Cai, Z. Li, C.W. Huang, R. Park, A.H. Shahinian and P.S. Conti, An improved synthesis and biological evaluation of a new cage-like bifunctional chelator, 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane-1-ylamino)methyl) benzoic acid, for 64Cu radiopharmaceuticals, Nucl Med Biol. 37 (2010) 57\u201365.","DOI":"10.1016\/j.nucmedbio.2009.09.001"},{"key":"10.1016\/j.addr.2010.08.004_bb0500","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1076-6332(96)80448-X","article-title":"Stable polymeric micelles: lymphangiographic contrast media for gamma scintigraphy and magnetic resonance imaging","volume":"3","author":"Trubetskoy","year":"1996","journal-title":"Acad. Radiol."},{"key":"10.1016\/j.addr.2010.08.004_bb0505","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1023\/A:1011951016118","article-title":"Accumulation of protein-loaded long-circulating micelles and liposomes in subcutaneous Lewis lung carcinoma in mice","volume":"15","author":"Weissig","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2010.08.004_bb0510","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/10611869709017895","article-title":"Block-copolymer of polyethylene glycol and polylysine as a carrier of organic iodine: design of long-circulating particulate contrast medium for X-ray computed tomography","volume":"4","author":"Trubetskoy","year":"1997","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2010.08.004_bb0515","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.1016\/j.biomaterials.2010.03.057","article-title":"Targeted near-IR QDs-loaded micelles for cancer therapy and imaging","volume":"31","author":"Nurunnabi","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2010.08.004_bb0520","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2217\/nnm.10.10","article-title":"Nanomicellar formulations for sustained drug delivery: strategies and underlying principles","volume":"5","author":"Trivedi","year":"2010","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.addr.2010.08.004_bb0525","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1021\/bm100116g","article-title":"Amphiphilic toothbrushlike copolymers based on poly(ethylene glycol) and poly(epsilon-caprolactone) as drug carriers with enhanced properties","volume":"11","author":"Zhang","year":"2010","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2010.08.004_bb0530","doi-asserted-by":"crossref","first-page":"7544","DOI":"10.1021\/la904355p","article-title":"Encapsulation of a hydrophobic drug into a polymer-micelle core explored with synchrotron SAXS","volume":"26","author":"Akiba","year":"2010","journal-title":"Langmuir"},{"key":"10.1016\/j.addr.2010.08.004_bb0535","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jconrel.2010.02.027","article-title":"A novel size-tunable nanocarrier system for targeted anticancer drug delivery","volume":"144","author":"Li","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2010.08.004_bb0540","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/asia.200900228","article-title":"Silica-coated metal nanoparticles","volume":"5","author":"Liu","year":"2010","journal-title":"Chem. Asian J."},{"key":"10.1016\/j.addr.2010.08.004_bb0545","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-1-60761-609-2_8","article-title":"Gold nanorods: multifunctional agents for cancer imaging and therapy","volume":"624","author":"Wei","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.addr.2010.08.004_bb0550","first-page":"2005","article-title":"Cancer imaging and therapy with metal nanoparticles","volume":"2009","author":"Sokolov","year":"2009","journal-title":"Conf. Proc. IEEE. Eng. Med. Biol. Soc."},{"key":"10.1016\/j.addr.2010.08.004_bb0555","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.addr.2009.03.007","article-title":"Magnetic nanoparticles for theragnostics","volume":"61","author":"Shubayev","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2010.08.004_bb0560","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/smll.200900389","article-title":"Drug\/dye-loaded, multifunctional iron oxide nanoparticles for combined targeted cancer therapy and dual optical\/magnetic resonance imaging","volume":"5","author":"Santra","year":"2009","journal-title":"Small"},{"key":"10.1016\/j.addr.2010.08.004_bb0565","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1592\/phco.30.1.70","article-title":"Ferumoxytol: a new intravenous iron preparation for the treatment of iron deficiency anemia in patients with chronic kidney disease","volume":"30","author":"Schwenk","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.addr.2010.08.004_bb0570","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ajh.21656","article-title":"FDA report: ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease","volume":"85","author":"Lu","year":"2010","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.addr.2010.08.004_bb0575","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1021\/nn900819y","article-title":"Conquering the dark side: colloidal iron oxide nanoparticles","volume":"3","author":"Senpan","year":"2009","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2010.08.004_bb0580","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nprot.2006.11","article-title":"Labeling of immune cells for in vivo imaging using magnetofluorescent nanoparticles","volume":"1","author":"Pittet","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.addr.2010.08.004_bb0585","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2217\/nnm.10.13","article-title":"Multifunctional nanoparticles of biodegradable copolymer blend for cancer diagnosis and treatment","volume":"5","author":"Pan","year":"2010","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.addr.2010.08.004_bb0590","doi-asserted-by":"crossref","first-page":"7090","DOI":"10.1021\/la900148m","article-title":"Biocompatible CdSe-ZnS core\u2013shell quantum dots coated with hydrophilic polythiols","volume":"25","author":"Yildiz","year":"2009","journal-title":"Langmuir"},{"key":"10.1016\/j.addr.2010.08.004_bb0595","doi-asserted-by":"crossref","first-page":"11503","DOI":"10.1021\/la1010488","article-title":"Hydrophilic CdSe-ZnS core\u2013shell quantum dots with reactive functional groups on their surface","volume":"26","author":"Yildiz","year":"2010","journal-title":"Langmuir"},{"key":"10.1016\/j.addr.2010.08.004_bb0600","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1021\/bc060261j","article-title":"Sentinel lymph node imaging using quantum dots in mouse tumor models","volume":"18","author":"Ballou","year":"2007","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2010.08.004_bb0605","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nbt920","article-title":"Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping","volume":"22","author":"Kim","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2010.08.004_bb0610","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/nbt994","article-title":"In vivo cancer targeting and imaging with semiconductor quantum dots","volume":"22","author":"Gao","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2010.08.004_bb0615","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nbt764","article-title":"Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots","volume":"21","author":"Wu","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2010.08.004_bb0620","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2967\/jnumed.108.053561","article-title":"Quantum dots for in vivo small-animal imaging","volume":"50","author":"Bentolila","year":"2009","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2010.08.004_bb0625","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/jbio.200810029","article-title":"Tracking bio-molecules in live cells using quantum dots","volume":"1","author":"Chang","year":"2008","journal-title":"J. Biophotonics"},{"key":"10.1016\/j.addr.2010.08.004_bb0630","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.canlet.2004.02.004","article-title":"Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles","volume":"209","author":"O'Neal","year":"2004","journal-title":"Cancer Lett."},{"key":"10.1016\/j.addr.2010.08.004_bb0635","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1158\/0008-5472.CAN-08-2535","article-title":"Feasibility study of particle-assisted laser ablation of brain tumors in orthotopic canine model","volume":"69","author":"Schwartz","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2010.08.004_bb0640","doi-asserted-by":"crossref","first-page":"018001","DOI":"10.1117\/1.3290817","article-title":"Photothermal therapy in a murine colon cancer model using near-infrared absorbing gold nanorods","volume":"15","author":"Goodrich","year":"2010","journal-title":"J. Biomed. Opt."},{"key":"10.1016\/j.addr.2010.08.004_bb0645","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1021\/ja068095d","article-title":"Enhanced sensitized NIR luminescence from gold nanoparticles via energy transfer from surface-bound fluorophores","volume":"129","author":"Montalti","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2010.08.004_bb0650","doi-asserted-by":"crossref","first-page":"7780","DOI":"10.1021\/ja035473v","article-title":"High quantum yield blue emission from water-soluble Au8 nanodots","volume":"125","author":"Zheng","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2010.08.004_bb0655","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1259\/bjr\/13169882","article-title":"Gold nanoparticles: a new X-ray contrast agent","volume":"79","author":"Hainfeld","year":"2006","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.addr.2010.08.004_bb0660","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2174\/157016308786733573","article-title":"Ultrasound techniques for drug delivery in cardiovascular medicine","volume":"5","author":"Landini","year":"2008","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.addr.2010.08.004_bb0665","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1021\/mp9001816","article-title":"Formulation and characterization of echogenic lipid-pluronic nanobubbles","volume":"7","author":"Krupka","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2010.08.004_bb0670","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1021\/ar8002442","article-title":"Lipid-shelled vehicles: engineering for ultrasound molecular imaging and drug delivery","volume":"42","author":"Ferrara","year":"2009","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.addr.2010.08.004_bb0675","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ultras.2007.11.002","article-title":"Drug-loaded nano\/microbubbles for combining ultrasonography and targeted chemotherapy","volume":"48","author":"Gao","year":"2008","journal-title":"Ultrasonics"},{"key":"10.1016\/j.addr.2010.08.004_bb0680","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/jnci\/djm043","article-title":"Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy","volume":"99","author":"Rapoport","year":"2007","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.addr.2010.08.004_bb0685","doi-asserted-by":"crossref","first-page":"85102","DOI":"10.1088\/0957-4484\/21\/8\/085102","article-title":"Tunable plasmonic nanobubbles for cell theranostics","volume":"21","author":"Lukianova-Hleb","year":"2010","journal-title":"Nanotechnology."},{"key":"10.1016\/j.addr.2010.08.004_bb0690","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1039\/b923921a","article-title":"Epr characterisation of platinum nanoparticle functionalised carbon nanotube hybrid materials","volume":"12","author":"Dennany","year":"2010","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.addr.2010.08.004_bb0695","doi-asserted-by":"crossref","first-page":"11467","DOI":"10.1021\/ja803036e","article-title":"Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device","volume":"130","author":"Dhar","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2010.08.004_bb0700","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1021\/nn800551s","article-title":"Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery","volume":"3","author":"Bhirde","year":"2009","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2010.08.004_bb0705","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2796.2009.02188.x","article-title":"The role of nanotoxicology in realizing the \u2018helping without harm\u2019 paradigm of nanomedicine: lessons from studies of pulmonary effects of single-walled carbon nanotubes","volume":"267","author":"Shvedova","year":"2010","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.addr.2010.08.004_bb0710","doi-asserted-by":"crossref","first-page":"10702","DOI":"10.1039\/b912708a","article-title":"Novel and emerging approaches for the delivery of metallo-drugs","author":"Sanchez-Cano","year":"2009","journal-title":"Dalton Trans."},{"key":"10.1016\/j.addr.2010.08.004_bb0715","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.addr.2009.03.010","article-title":"Effects of nanomaterial physicochemical properties on in vivo toxicity","volume":"61","author":"Aillon","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2010.08.004_bb0720","doi-asserted-by":"crossref","first-page":"5844","DOI":"10.1073\/pnas.0710575105","article-title":"Noninvasive molecular imaging of small living subjects using Raman spectroscopy","volume":"105","author":"Keren","year":"2008","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.addr.2010.08.004_bb0725","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1021\/nl072509z","article-title":"Noncovalent functionalization of carbon nanotubes with amphiphilic Gd3+ chelates: toward powerful T1 and T2 MRI contrast agents","volume":"8","author":"Richard","year":"2008","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2010.08.004_bb0730","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.2967\/jnumed.106.039131","article-title":"Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes","volume":"48","author":"McDevitt","year":"2007","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2010.08.004_bb0735","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nnano.2006.170","article-title":"In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice","volume":"2","author":"Liu","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.addr.2010.08.004_bb0740","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2217\/nnm.09.58","article-title":"The future of theranostic nanoagents","volume":"4","author":"McCarthy","year":"2009","journal-title":"Nanomedicine"},{"key":"10.1016\/j.addr.2010.08.004_bb0745","first-page":"437","article-title":"Thermal dosimetry predictive of efficacy of In-111-Chl6 nanoparticle AMF-induced thermoablative therapy for human breast cancer in mice","volume":"48","author":"DeNardo","year":"2007","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2010.08.004_bb0750","doi-asserted-by":"crossref","first-page":"7187 s","DOI":"10.1158\/1078-0432.CCR-1004-0013","article-title":"Enhancement of the therapeutic index: from nonmyeloablative and myeloablative toward pretargeted radioimmunotherapy for metastatic prostate cancer","volume":"11","author":"DeNardo","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2010.08.004_bb0755","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00259-009-1104-2","article-title":"Nanoparticles for concurrent multimodality imaging and therapy: the dawn of new theragnostic synergies","volume":"36","author":"Lucignani","year":"2009","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.addr.2010.08.004_bb0760","doi-asserted-by":"crossref","unstructured":"M. Baiker, J. Milles, J. Dijkstra, T.D. Henning, A.W. Weber, I. Que, E.L. Kaijzel, C.W. Lowik, J.H. Reiber and B.P. Lelieveldt, Atlas-based whole-body segmentation of mice from low-contrast micro-CT data, Med Image Anal. 14 (2010) 723\u2013737.","DOI":"10.1016\/j.media.2010.04.008"},{"key":"10.1016\/j.addr.2010.08.004_bb0765","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nm1724","article-title":"Molecular imaging of lymphoid organs and immune activation by positron emission tomography with a new [18F]-labeled 2\u2032-deoxycytidine analog","volume":"14","author":"Radu","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2010.08.004_bb0770","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/sj.gt.3302674","article-title":"Infectivity enhancement for adenoviral transduction of canine osteosarcoma cells","volume":"13","author":"Le","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.addr.2010.08.004_bb0775","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1471-2407-9-106","article-title":"Complementarity of ultrasound and fluorescence imaging in an orthotopic mouse model of pancreatic cancer","volume":"9","author":"Snyder","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.addr.2010.08.004_bb0780","doi-asserted-by":"crossref","first-page":"8836","DOI":"10.1002\/anie.200703554","article-title":"Multifunctional magneto-polymeric nanohybrids for targeted detection and synergistic therapeutic effects on breast cancer","volume":"46","author":"Yang","year":"2007","journal-title":"Angew. Chem. Int. Ed Engl."},{"key":"10.1016\/j.addr.2010.08.004_bb0785","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nm1486","article-title":"In vivo imaging of siRNA delivery and silencing in tumors","volume":"13","author":"Medarova","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2010.08.004_bb0790","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1021\/nl052405t","article-title":"Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects","volume":"6","author":"Cai","year":"2006","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2010.08.004_bb0795","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc701","article-title":"Scaling down imaging: Molecular mapping of cancer in mice","volume":"2","author":"Weissleder","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.addr.2010.08.004_bb0800","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/ATVBAHA.108.165506","article-title":"Nanotechnology in medical imaging: Probe design and applications","volume":"29","author":"Cormode","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.addr.2010.08.004_bb0805","doi-asserted-by":"crossref","unstructured":"D. Kim, S. Park, J.H. Lee, Y.Y. Jeong, S. Jon, Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo x-ray computed tomography imaging, J. Am. Chem. Soc. 129 (2007) 7661\u20137665.","DOI":"10.1021\/ja071471p"},{"key":"10.1016\/j.addr.2010.08.004_bb0810","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1101\/gad.1047403","article-title":"Molecular imaging in living subjects: Seeing fundamental biological processes in a new light","volume":"17","author":"Massoud","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.addr.2010.08.004_bb0825","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.addr.2009.04.020","article-title":"Novel nanomedicine-based mri contrast agents for gynecological malignancies","volume":"61","author":"Mody","year":"2009","journal-title":"Adv. Drug Reliv. Rev."},{"key":"10.1016\/j.addr.2010.08.004_bb0815","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature05541","article-title":"Restoration of p53 function leads to tumour regression in vivo","volume":"445","author":"Ventura","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.addr.2010.08.004_bb0820","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/nm.1864","article-title":"Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors","volume":"14","author":"Fu","year":"2008","journal-title":"Nature Medicine"}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X10001705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X10001705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T10:25:41Z","timestamp":1711707941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X10001705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":165,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0169409X10001705"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2010.08.004","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}